A Two-Part, Phase 2/3, Double-blind, Randomized, Active-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of LBP-EC01 in the Treatment of Acute Uncomplicated Urinary Tract Infection Caused

Project: Research project

Project Details

StatusActive
Effective start/end date6/13/246/12/26

Funding

  • Locus Biosciences Inc ( Award #75A50120C00169): $81,083.00